Inventor · disambiguated record
Dominique Schols
Also filed as: SCHOLS DOMINIQUE
33 granted patents·15 pending applications·640 citations·filing 1993–2022
98Inventor score
Top patents by PatentIndex Score
48 records- 0196US7863293B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2007·Granted Jan 4, 2011·24 cites·18 claims
- 0295US7291631B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2004·Granted Nov 6, 2007·50 cites·25 claims
- 0394US7709486B2CXCR4 antagonistsGENZYME CORP·Filed 2008·Granted May 4, 2010·20 cites·6 claims
- 0494US7354934B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2005·Granted Apr 8, 2008·34 cites·10 claims
- 0594US6864265B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Mar 8, 2005·42 cites·6 claims
- 0694US6750348B1Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2000·Granted Jun 15, 2004·61 cites·30 claims
- 0793US7091217B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Aug 15, 2006·31 cites·12 claims
- 0893US6835731B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Dec 28, 2004·53 cites·10 claims
- 0993US6734191B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted May 11, 2004·35 cites·15 claims
- 1090US7354932B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2003·Granted Apr 8, 2008·27 cites·21 claims
- 1189US9005963B2Amino acid sequences directed against cellular receptors for viruses and bacteriaBLANCHETOT CHRISTOPHE·Filed 2009·Granted Apr 14, 2015·13 cites·18 claims
- 1289US8778967B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2012·Granted Jul 15, 2014·18 cites·20 claims
- 1389US6756391B2Antiviral compoundsANORMED INC·Filed 2002·Granted Jun 29, 2004·23 cites·7 claims
- 1488US7414065B2Methods to modulate conditions mediated by the CXCR4 receptorGENZYME CORP·Filed 2004·Granted Aug 19, 2008·20 cites·8 claims
- 1588US7160872B2Methods to treat conditions mediated by chemokine receptorsANORMED INC·Filed 2004·Granted Jan 9, 2007·20 cites·12 claims
- 1688US6506770B1Antiviral compoundsANORMED INC·Filed 1998·Granted Jan 14, 2003·53 cites·7 claims
- 1784US7550484B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2004·Granted Jun 23, 2009·19 cites·11 claims
- 1884US6667320B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2000·Granted Dec 23, 2003·17 cites·19 claims
- 1983US6872714B1Methods to modulate conditions mediated by the CXCR4 receptorANORMED INC·Filed 1999·Granted Mar 29, 2005·35 cites·7 claims
- 2080US9803018B2Amino acid sequences directed against cellular receptors for viruses and bacteriaABLYNX NV·Filed 2015·Granted Oct 31, 2017·2 cites·14 claims
- 2176US10273305B2Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activityABLYNX NV·Filed 2016·Granted Apr 30, 2019·2 cites·17 claims
- 2276US7396840B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Jul 8, 2008·1 cites·9 claims
- 2375US10322111B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2016·Granted Jun 18, 2019·1 cites·13 claims
- 2475US7312234B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Dec 25, 2007·7 cites·6 claims
- 2573US7629337B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Dec 8, 2009·1 cites·9 claims
- 2669US7084155B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Aug 1, 2006·3 cites·15 claims
- 2768US7022717B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2003·Granted Apr 4, 2006·2 cites·11 claims
- 2867US7183273B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Feb 27, 2007·2 cites·10 claims
- 2967US2020000774A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2019·Application pending·0 cites
- 3064US2022242958A1Bispecific nanobodiesABLYNX NV·Filed 2021·Application pending·0 cites
- 3163US2015038509A1Chemokine Receptor Binding Heterocyclic Compounds With Enhanced EfficacyGENZYME CORP·Filed 2014·Application pending·0 cites
- 3262US7807694B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Oct 5, 2010·0 cites·4 claims
- 3362US2008167341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2008·Application pending·0 cites
- 3461US2010105915A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY J·Filed 2009·Application pending·0 cites
- 3560US2007060591A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY J·Filed 2006·Application pending·0 cites
- 3659US2009281308A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY J·Filed 2009·Application pending·0 cites
- 3759US2022409589A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2022·Application pending·0 cites
- 3858US11046773B2Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activityABLYNX NV·Filed 2019·Granted Jun 29, 2021·0 cites·16 claims
- 3958US2024293391A1Isoquinoline and pyridine based cxcr4 antagonistsUNIV LEUVEN KATH·Filed 2022·Application pending·0 cites
- 4058US2006069129A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY J·Filed 2005·Application pending·0 cites
- 4158US2009048222A1Triaza Compound Immunoregulatory AgentsBELL THOMAS·Filed 2007·Application pending·0 cites
- 4257US2008090846A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY·Filed 2007·Application pending·0 cites
- 4351US5869457AModified proteins and their use for controlling viral infectionsUNIV GRONINGEN·Filed 1997·Granted Feb 9, 1999·16 cites·32 claims
- 4451US2016251440A1Bispecific nanobodiesABLYNX NV·Filed 2014·Application pending·0 cites
- 4549US2003220341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyFiled 2002·Application pending·0 cites
- 4643US5596018AAntiviral agents against aids-causing virusTORAY INDUSTRIES·Filed 1993·Granted Jan 21, 1997·8 cites·4 claims
- 4742US2004220164A1Triaza compound immunoregulatory agentsFiled 2003·Application pending·0 cites
- 4836US11040047B2Prodrugs of nucleoside phosphonatesUNIV LEUVEN KATH·Filed 2018·Granted Jun 22, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Dominique Schols files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →